MOLN - Molecular Partners AG - ADR
IEX Last Trade
5.71
-0.770 -13.485%
Share volume: 10,373
Last Updated: Fri 30 Aug 2024 09:46:56 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.48
-0.77
-11.88%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-8.83%
1 Month
-10.90%
3 Months
39.56%
6 Months
32.09%
1 Year
-4.70%
2 Year
-3.40%
Key data
Stock price
$5.71
DAY RANGE
N/A - N/A
52 WEEK RANGE
$3.32 - $12.70
52 WEEK CHANGE
-$0.05
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Patrick Amstutz
Region: US
Website: https://www.molecularpartners.com/
Employees: 0
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.molecularpartners.com/
Employees: 0
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Recent news